M. B. Mulder, “Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial)”, AO, vol. 60, no. 4, pp. 539–543, Apr. 2021.